These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 25592694)
1. Lipoprotein-associated phospholipase A2 and aortic stenosis: biomarker or new target for an old foe? Heistad D; Doshi H JACC Cardiovasc Imaging; 2015 Jan; 8(1):34-36. PubMed ID: 25592694 [No Abstract] [Full Text] [Related]
2. Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study. Capoulade R; Mahmut A; Tastet L; Arsenault M; Bédard É; Dumesnil JG; Després JP; Larose É; Arsenault BJ; Bossé Y; Mathieu P; Pibarot P JACC Cardiovasc Imaging; 2015 Jan; 8(1):26-33. PubMed ID: 25499129 [TBL] [Abstract][Full Text] [Related]
4. New therapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized phospholipid axis. Hung MY; Witztum JL; Tsimikas S J Am Coll Cardiol; 2014 Feb; 63(5):478-80. PubMed ID: 24161316 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis. Kolasa-Trela R; Fil K; Bazanek M; Grudzień G; Sobczyk D; Sadowski J; Undas A Clin Chem Lab Med; 2012 Oct; 50(10):1825-31. PubMed ID: 23089713 [TBL] [Abstract][Full Text] [Related]
6. The emerging role of lipoprotein-associated phospholipase A2 in cerebrovascular disease. Kakkos SK; Tsolakis IA Eur J Vasc Endovasc Surg; 2012 Feb; 43(2):160. PubMed ID: 22119229 [No Abstract] [Full Text] [Related]
7. Circulating Lp-PLA2 is associated with high valvuloarterial impedance and low arterial compliance in patients with aortic valve bioprostheses. Mahmut A; Mahjoub H; Boulanger MC; Dahou A; Bouchareb R; Capoulade R; Arsenault BJ; Larose E; Bossé Y; Pibarot P; Mathieu P Clin Chim Acta; 2016 Apr; 455():20-5. PubMed ID: 26797670 [TBL] [Abstract][Full Text] [Related]
8. Role of lipoprotein-associated phospholipase A2 in predicting risk of cardiovascular disease. Myerson M Mayo Clin Proc; 2007 Jul; 82(7):888; author reply 888-9. PubMed ID: 17605973 [No Abstract] [Full Text] [Related]
9. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments. Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135 [TBL] [Abstract][Full Text] [Related]
10. [Concentration of Lipoprotein-Associated Phospholipase A2 in Patients With Ischemic Heart Disease]. Noruzbaeva AM; Osmankulova GE; Aldashev AA; Mainazarova ES Kardiologiia; 2016 Jan; 56(1):49-50. PubMed ID: 28294732 [No Abstract] [Full Text] [Related]
11. Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis. Yeang C; Wilkinson MJ; Tsimikas S Curr Opin Cardiol; 2016 Jul; 31(4):440-50. PubMed ID: 27205885 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China. Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599 [TBL] [Abstract][Full Text] [Related]